Diagnostic and prognostic utility of PD-1 in B cell lymphomas.
about
Catching up with solid tumor oncology: what is the evidence for a prognostic role of programmed cell death-ligand 1/programmed cell death-1 expression in B-cell lymphomas?The expression and clinical relevance of PD-1, PD-L1, and TP63 in patients with diffuse large B-cell lymphomaImmune checkpoint blockade: the role of PD-1-PD-L axis in lymphoid malignancies.PD1 is highly expressed in diffuse large B-cell lymphoma with hepatitis B virus infection.Upregulation of PD-L1 and APE1 is associated with tumorigenesis and poor prognosis of gastric cancer.PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survivalDUSP4 deficiency caused by promoter hypermethylation drives JNK signaling and tumor cell survival in diffuse large B cell lymphomaGenetic absence of PD-1 promotes accumulation of terminally differentiated exhausted CD8+ T cellsExpression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma.Follicular lymphomas in children and young adults: a comparison of the pediatric variant with usual follicular lymphoma.Lymphocyte-to-monocyte ratio is associated with prognosis of diffuse large B-cell lymphoma: correlation with CD163 positive M2 type tumor-associated macrophages, not PD-1 positive tumor-infiltrating lymphocytes.Follicular helper T cells: implications in neoplastic hematopathology.Programmed death 1 and B and T lymphocyte attenuator immunoreceptors and their association with malignant T-lymphoproliferative disorders: brief review.Pidilizumab in the treatment of diffuse large B-cell lymphoma.The PD-1/PD-L1 pathway: biological background and clinical relevance of an emerging treatment target in immunotherapy.The immune system and cancer evasion strategies: therapeutic concepts.The emerging role of immune checkpoint inhibition in malignant lymphoma.Mechanisms of PD-1/PD-L1 expression and prognostic relevance in non-Hodgkin lymphoma: a summary of immunohistochemical studies.The immunophenotypic spectrum of primary mediastinal large B-cell lymphoma reveals prognostic biomarkers associated with outcome.Nodal reactive and neoplastic proliferation of monocytoid and marginal zone B cells: an immunoarchitectural and molecular study highlighting the relevance of IRTA1 and T-bet as positive markers.Programmed death-1 expression in cutaneous B-cell lymphoma.PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?PD-1 expression and clinical PD-1 blockade in B-cell lymphomas.Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL.EBV infection determines the immune hallmarks of plasmablastic lymphoma
P2860
Q28076071-CABA6363-8C49-4CB5-BF94-DEC668C0606EQ33597192-4D20F1F5-7631-4404-924F-D15D796AB270Q33638083-D16FAC18-2133-49FF-A2E9-38C4145B7234Q33853605-6DFDCFAF-A495-4122-820A-594ADFD8FF74Q35113261-4F72CC1E-6DA0-47D8-BD49-728617031EDEQ35146249-24E336F9-9786-4264-8802-88CF24C82856Q35568457-FC2B3B52-7B5A-4129-9D80-FFC8BFCBE026Q35824223-4805E301-7DE0-48CC-915F-C0B62534EF42Q36253967-94B14971-6B1E-47CD-81DD-2B7A02648BEDQ36592504-205CCA8D-A7ED-49FD-96CA-83F4F6D9FB8CQ37706368-EC34BCCE-C9D9-4164-84AB-E2B0BA86A203Q37919491-45B96282-2E2C-4735-AB56-571F0E1FEB12Q38137911-FB872082-CF00-49A6-81FB-A3A3CACB5F5CQ38233257-4E4F741C-785E-4206-9D0F-7FA30B658574Q38285859-237566A8-81FE-4784-BA04-B58BCA8492F6Q38691172-6D6DBD80-EFFF-4B75-A6CB-CC03A76AFDE2Q38791036-9E6E1F0E-293C-4731-8129-0CA116CA7E16Q39237785-43D2C63B-1BAB-4CB9-A304-B87B4C10D66DQ40649778-6268DBAB-CC51-4B8F-8E2B-3603FEA45DCAQ45896157-02B3AE71-ABBB-4890-A073-C4CB80C436C8Q46308170-9D4803B4-0D56-47BD-9ACA-4403DE58B698Q47120629-34D62F41-31CD-469B-A425-847D6F215FF4Q47424027-F9206C3D-F2FC-4C4F-9DF9-25878F37ED34Q50716088-0E608A21-1ED5-4497-94DA-824C176D5ACEQ56968100-A1AA54A2-9E43-4180-97D6-6DD7122A087D
P2860
Diagnostic and prognostic utility of PD-1 in B cell lymphomas.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Diagnostic and prognostic utility of PD-1 in B cell lymphomas.
@en
Diagnostic and prognostic utility of PD-1 in B cell lymphomas.
@nl
type
label
Diagnostic and prognostic utility of PD-1 in B cell lymphomas.
@en
Diagnostic and prognostic utility of PD-1 in B cell lymphomas.
@nl
prefLabel
Diagnostic and prognostic utility of PD-1 in B cell lymphomas.
@en
Diagnostic and prognostic utility of PD-1 in B cell lymphomas.
@nl
P2093
P356
P1433
P1476
Diagnostic and prognostic utility of PD-1 in B cell lymphomas.
@en
P2093
P356
10.1155/2010/404069
P577
2010-01-01T00:00:00Z